missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ TRAILR2/TNFRSF10B Antibody (drozitumab), Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28785-50ug
This item is not returnable.
View return policy
Description
TRAILR2/TNFRSF10B Monoclonal antibody specifically detects TRAILR2/TNFRSF10B in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| TRAILR2/TNFRSF10B | |
| Monoclonal | |
| Unconjugated | |
| O14763 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| drozitumab | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| CD262, CD262 antigen, death domain containing receptor for TRAIL/Apo-2L, Death receptor 5, DR5TRICK2B, Fas-like protein, KILLER/DR5, KILLERapoptosis inducing protein TRICK2A/2B, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2apoptosis inducing receptor TRAIL-R2, TRAILR2cytotoxic TRAIL receptor-2, TRICK2, TRICK2A, TRICKB, tumor necrosis factor receptor superfamily member 10B, tumor necrosis factor receptor superfamily, member 10b, tumor necrosis factor receptor-like protein ZTNFR9, ZTNFR9 | |
| TNFRSF10B/ TRAILR2/ CD262 | |
| 50 μg | |
| Apoptosis, Biologically Active Proteins, Cancer, Death Receptor Signaling Pathway | |
| 8795 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction